Today: 22 January 2026
Subscribe
Browse Category

Pharmaceuticals News 6 January 2026 - 7 January 2026

Merck stock in focus after CDC rewrites childhood vaccine schedule, puts Gardasil dosing under a microscope

Merck stock in focus after CDC rewrites childhood vaccine schedule, puts Gardasil dosing under a microscope

New York, Jan 6, 2026, 20:54 (ET) — Market closed Merck & Co. shares rose 1.3% to $108.87 on Tuesday, after U.S. health officials overhauled the childhood immunization schedule and shifted several vaccines away from broad, routine recommendations. The Health and Human Services Department said the revised schedule keeps a core set of vaccines as routine for all children and…
7 January 2026
·
Eli Lilly stock rises after hours on Nimbus obesity pill deal as Ventyx talks surface

Eli Lilly stock rises after hours on Nimbus obesity pill deal as Ventyx talks surface

New York, January 6, 2026, 18:18 EST — After-hours Eli Lilly and Company stock closed up 2.2% on Tuesday and was up about 0.1% in after-hours trading after Nimbus Therapeutics said it struck a research and licensing deal with the drugmaker to pursue an oral obesity treatment. Yahoo Finance The news lands as investors look for the next leg of…
7 January 2026
···
Johnson & Johnson stock ticks up on lupus drug data as earnings loom

Johnson & Johnson stock ticks up on lupus drug data as earnings loom

New York, January 6, 2026, 12:58 EST — Regular session Johnson & Johnson (JNJ.N) shares rose on Tuesday after the company reported positive mid-stage data for its experimental lupus drug nipocalimab and outlined plans for late-stage testing. The stock was up $1.10, or 0.5%, at $205.41 in midday New York trading. The update puts fresh focus on J&J’s drug pipeline…
6 January 2026
····
AbbVie stock nudges higher after Canada clears Maviret — what ABBV investors watch next

AbbVie stock nudges higher after Canada clears Maviret — what ABBV investors watch next

New York, January 6, 2026, 12:36 PM ET — Regular session AbbVie shares rose about 0.5% to $221.18 in midday trading on Tuesday after the drugmaker said Health Canada approved its hepatitis C therapy Maviret (glecaprevir/pibrentasvir) for acute and chronic infections. The clearance expands use of an eight-week oral regimen and supports “treat early” strategies aimed at cutting transmission by…
6 January 2026
···
Moderna stock jumps nearly 11% after BofA target lift; flu vaccine filing in focus

Moderna stock jumps nearly 11% after BofA target lift; flu vaccine filing in focus

NEW YORK, January 6, 2026, 12:28 EST — Regular session Shares of Moderna Inc (MRNA.O) were up 10.7% at $35.60 in midday trading on Tuesday after BofA Global Research raised its price objective on the vaccine maker. The stock touched a session high of $36.25. Reuters The jump comes as investors weigh whether Moderna can turn its mRNA platform into…
6 January 2026
···
Arrowhead stock leaps after gene-silencing obesity drug doubles Lilly’s Zepbound weight loss

Arrowhead stock leaps after gene-silencing obesity drug doubles Lilly’s Zepbound weight loss

New York, Jan 6, 2026, 11:34 AM EST — Regular session Arrowhead Pharmaceuticals shares rose about 16% on Tuesday after early clinical data showed its experimental gene-silencing obesity drug boosted weight loss when used alongside Eli Lilly’s tirzepatide, sold as Zepbound. The stock was up 16% at $74.13 in midday trading, after swinging between $62.17 and $76.32. Investors The update…
6 January 2026
·
Eli Lilly stock rises on Nimbus obesity pill pact as oral drug race heats up

Eli Lilly stock rises on Nimbus obesity pill pact as oral drug race heats up

New York, January 6, 2026, 10:55 EST — Regular session Eli Lilly and Company (LLY) shares rose about 1.6% on Tuesday after Nimbus Therapeutics announced a research and licensing agreement with the drugmaker aimed at developing an oral obesity treatment. Lilly was trading at $1,057.80 in New York morning trade, after moving between $1,040.15 and $1,070.77 earlier in the session.…
6 January 2026
···
Novo Nordisk (NVO) stock jumps as $149 Wegovy pill rollout puts pricing in the spotlight

Novo Nordisk (NVO) stock jumps as $149 Wegovy pill rollout puts pricing in the spotlight

New York, Jan 6, 2026, 10:40 EST — Regular session Novo Nordisk A/S shares listed in New York as ADRs climbed about 4.7% to $57.71 on Tuesday, after touching an intraday high of $58.14. The move extends a rebound sparked by the U.S. rollout of a pill version of Wegovy, a franchise that has become central to how investors value…
6 January 2026
····
Alumis stock jumps 129% after Phase 3 psoriasis data; ALMS hits new 52-week high

Alumis stock jumps 129% after Phase 3 psoriasis data; ALMS hits new 52-week high

New York, January 6, 2026, 09:49 EST — Regular session Alumis Inc (ALMS) shares jumped about 129% in early trade on Tuesday after the drugmaker reported positive late-stage data for its psoriasis pill, envudeucitinib. The stock was at $19.04, up from a previous close of $8.31, after touching $22.30 to set a new 52-week high, Google Finance data showed. Google…
6 January 2026
···
AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next

AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next

NEW YORK, Jan 6, 2026, 08:02 EST — Premarket AbbVie shares were flat in premarket trading on Tuesday after the drugmaker said Health Canada had approved its hepatitis C pill Maviret for both acute and chronic infection. AbbVie stock last traded at $220.18. The expanded label matters because it opens the door to treatment soon after diagnosis, when infections are…
6 January 2026
··
Novo Nordisk stock jumps premarket as $149 Wegovy pill hits U.S. market

Novo Nordisk stock jumps premarket as $149 Wegovy pill hits U.S. market

New York, January 6, 2026, 07:27 EST — Premarket Novo Nordisk’s U.S.-listed shares rose about 4% in premarket trading on Tuesday, extending gains after the Danish drugmaker began selling its once-daily Wegovy weight-loss pill in the United States. The stock was up at $57.29, compared with a prior close of $55.11. Public The launch lands as investors debate how fast…
6 January 2026
····
1 … 11 12 13 14 15 … 46

Stock Market Today

  • Thursday Sector Leaders: Precious Metals and Metals & Mining Stocks Rally
    January 22, 2026, 1:03 PM EST. On Thursday, precious metals shares gained around 1.5%, led by Avino Silver & Gold Mines which surged 6.4%, and Harmony Gold Mining, up 5.9%. Metals & mining stocks also rose by approximately 1.3%, with Atlas Lithium soaring 16.1% and Idaho Strategic Resources climbing 7%. These moves highlight investor interest in mining sector equities amid broader market activity.
Go toTop